Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain

The distribution of D1 and D2 receptors was studied in coronal sections of rat brain, using quantitative autoradiography. D1 receptors were labeled with 1.8 nM 3H-SKF-83566 (a brominated analog of 3H-SCH-23390), while D2 receptors were labeled with 1.0 nM 3H-spiroperidol (3H-SPD). The binding of both ligands to sections from brain and from a homogenate of caudate putamen (CPu mash) reached equilibrium within 80 min at 37 degrees C. CPu mash provided a virtually unlimited number of homogeneous sections that contained a high density of both D1 and D2 receptors. Sections of CPu mash were used in competition studies that confirmed that the specific binding of 3H-SKF-83566 was selective for D1 receptors, and that the binding of 3H-SPD was selective for D2 receptors. Scatchard analysis of equilibrium binding of the 2 ligands in the CPu in horizontal sections of rat brain revealed Kd values of 1.1 +/- 0.07 nM for 3H-SKF-83566 and 0.7 +/- 0.09 nM for 3H-SPD. Studies of the distribution of D1 and D2 receptors were carried out in coronal sections of brains from 5 rats. D1 receptors were found throughout the forebrain and were present in greater density than were D2 receptors in all regions examined except the olfactory nerve layer. In the CPu, nucleus accumbens, and olfactory tubercle, the densities of D1 and D2 receptors were, respectively, approximately 2,500 and 600–800 fmol/mg protein. In the substantia nigra, the density of D1 receptors was approximately 2,500 fmol/mg protein in both the compacta and the reticulata, but the density of D2 receptors was 230 fmol/mg protein in the compacta and 70 fmol/mg protein in the reticulata. The ventral tegmental area contained only 90 fmol/mg protein of D1 receptors, and D2 receptors were undetectable. The entopeduncular nucleus, zona incerta, and region of the ventral internal capsule had densities of D1 receptors of 550–950 fmol/mg protein and D2 receptor densities of less than 100 fmol/mg protein. Densities of D1 and D2 receptors were, respectively, 2,700 and 900 fmol/mg protein in the choroid plexus. Knowledge of the differences in the relative distributions of D1 and D2 receptors in various brain regions may increase our understanding of the functions of brain dopaminergic systems and may aid in the development of new therapeutic approaches for neuropsychiatric disorders.

[1]  J. Hyttel SCH 23390 - the first selective dopamine D-1 antagonist. , 1983, European journal of pharmacology.

[2]  M. Kuhar,et al.  Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions. , 1980, European journal of pharmacology.

[3]  H. Yamamura,et al.  Use of autoradiographic techniques for the localization of neurotransmitter receptors in brain and periphery: recent applications. , 1984, Advances in experimental medicine and biology.

[4]  J. Kebabian,et al.  The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390. , 1984, European journal of pharmacology.

[5]  P. Seeman,et al.  Complete Conversion of Brain D2 Dopamine Receptors from the High‐ to the Low‐Affinity State for Dopamine Agonists, Using Sodium Ions and Guanine Nucleotide , 1985, Journal of neurochemistry.

[6]  J. Fallon,et al.  Catecholamine innervation of the basal forebrain IV. Topography of the dopamine projection to the basal forebrain and neostriatum , 1978, The Journal of comparative neurology.

[7]  P. Emson,et al.  Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra , 1979, Brain Research.

[8]  R. Mailman,et al.  SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions. , 1984, European journal of pharmacology.

[9]  F. J. White,et al.  Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. , 1983, Science.

[10]  G. Breese,et al.  SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons. , 1985, European journal of pharmacology.

[11]  A. Guidotti,et al.  Dopamine-sensitive adenylate cyclase: location in substantia nigra. , 1977, Science.

[12]  J. Waddington,et al.  Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390. , 1984, European journal of pharmacology.

[13]  C. Altar,et al.  Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol. , 1985, The Journal of pharmacology and experimental therapeutics.

[14]  J. Kebabian,et al.  Pharmacological and Biochemical Evidence for the Existence of Two Categories of Dopamine Receptor , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[15]  J. Glowinski,et al.  Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase — Interaction of d-LSD with dopaminergic receptors , 1976, Brain Research.

[16]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[17]  A. Barnett,et al.  SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. , 1983, The Journal of pharmacology and experimental therapeutics.

[18]  M. Kuhar,et al.  Neuroleptic and dopamine receptors: Autoradiographic localization of [3H]spiperone in rat brain , 1979, Brain Research.

[19]  I. Creese,et al.  Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. , 1984, Biochemical pharmacology.

[20]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[21]  M. Dubocovich,et al.  Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum. , 1983, The Journal of pharmacology and experimental therapeutics.

[22]  P. Greengard,et al.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  T. Dawson,et al.  D-1 dopamine receptors in the rat brain: autoradiographic localization using [3H]SCH 23390. , 1985, European journal of pharmacology.

[24]  P. Seeman,et al.  Anti-schizophrenic drugs--membrane receptor sites of action. , 1977, Biochemical pharmacology.

[25]  L. Swanson The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .

[26]  P. Molinoff,et al.  A Comprehensive Method for the Quantitative Determination of Dopamine Receptor Subtypes a , 1984, Annals of the New York Academy of Sciences.

[27]  E. Ohlstein,et al.  SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors. , 1985, European journal of pharmacology.

[28]  P Riederer,et al.  Bimodal distribution of dopamine receptor densities in brains of schizophrenics. , 1984, Science.

[29]  S. Crooke,et al.  Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566. , 1986, Life sciences.

[30]  T. Dawson,et al.  D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[32]  Quantitative receptor autoradiography: application to the characterization of multiple receptor subtypes. , 1984, Journal of receptor research.

[33]  J. Larsen,et al.  Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. , 1984, Life sciences.

[34]  J. Palacios,et al.  [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors , 1981, Brain Research.

[35]  D. Calne Dopamine receptors in movement disorders , 1981 .

[36]  M. Kuhar,et al.  Quantitative receptor mapping by autoradiography: some current technical problems , 1985, Trends in Neurosciences.

[37]  J. Bockaert,et al.  Topographical distributions of 32K and 48K cAMP-regulated phosphoproteins: Relationships to dopamine and serotonin innervations in striatum, substantia nigra and cerebral cortex , 1984, Brain Research.

[38]  K. Fuxe,et al.  Evidence for the existence of a dopamine receptor of the D-1 type in the rat median eminence , 1983, Neuroscience Letters.

[39]  D. Sibley,et al.  The classification of dopamine receptors: relationship to radioligand binding. , 1983, Annual review of neuroscience.

[40]  M. Herkenham,et al.  Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M Mishkin,et al.  Amygdalectomy impairs crossmodal association in monkeys. , 1985, Science.

[42]  C. Altar,et al.  Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: Plasticity of neostriatal dopamine receptors after nigrostriatal injury , 1984, Brain Research.

[43]  I. Creese,et al.  Dopamine receptor turnover rates in rat striatum are age-dependent. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Laduron Brain Dopamine Receptor: Multiple Binding Sites or Physiological Receptor Site , 1982 .

[45]  W. Nauta,et al.  Efferent connections of the substantia nigra and ventral tegmental area in the rat , 1979, Brain Research.

[46]  A. Biegon,et al.  Quantitative receptor autoradiography with tritium-labeled ligands: comparison of biochemical and densitometric measurements , 1984, Journal of Neuroscience Methods.

[47]  J. Leysen,et al.  A serotonergic component of neuroleptic receptors. , 1977, Archives internationales de pharmacodynamie et de therapie.

[48]  Michael J. Kuhar,et al.  Receptor autoradiography with tritium-sensitive film: Potential for computerized densitometry , 1981, Neuroscience Letters.

[49]  T. L. Neal,et al.  The rat claustrum: Afferent and efferent connections with visual cortex , 1985, Brain Research.

[50]  J. Kebabian,et al.  Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra , 1978, Brain Research.

[51]  R. Roth CNS Dopamine Autoreceptors: Distribution, Pharmacology, and Function a , 1984, Annals of the New York Academy of Sciences.

[52]  J. Joyce,et al.  Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation , 1985, Brain Research.

[53]  A. Barnett,et al.  Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. , 1984, Life sciences.

[54]  P. Greengard,et al.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.